The patient's perspective of the adverse effects of glucocorticoid use: A systematic review of quantitative and qualitative studies. From an OMERACT working group-Reference-Cited by-同舟云学术

The patient's perspective of the adverse effects of glucocorticoid use: A systematic review of quantitative and qualitative studies. From an OMERACT working group

Published:2020-10 Issue:5 Volume:50 Page:996-1005
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Cheah Jonathan T.L.,Robson Joanna C.,Black Rachel J.,Goodman Susan M.,Lester Susan,Mackie Sarah L.,Hill Catherine L.

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference46 articles.

1. Systemic glucocorticoid use in Denmark: a population-based prevalence study;Laugesen;BMJ Open,2017

2. Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis;Hoes;Ann Rheum Dis,2009

3. Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis;Jayne;J Am Soc Nephrol,2017

4. Trial of tocilizumab in giant-cell arteritis;Stone;N Engl J Med,2017

5. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force;Strehl;Ann Rheum Dis,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steroid-induced psychosis: a spectrum of neuropsychiatric glucocorticoid side effects;BMJ Case Reports;2024-07

2. Treatment goals in ANCA-associated vasculitis: defining success in a new era;Frontiers in Immunology;2024-06-13

3. Consensus of the definitions of the OMERACT glucocorticoid impact core domain set for people with rheumatic and musculoskeletal diseases;Seminars in Arthritis and Rheumatism;2024-02

4. Neuropsychiatric Adverse Effects of Synthetic Glucocorticoids: A Systematic Review and Meta-Analysis;The Journal of Clinical Endocrinology & Metabolism;2023-12-01

5. Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group;Seminars in Arthritis and Rheumatism;2023-12